Today’s AI Top Pick: GPI

8/12/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live GPI price forecast →

Today's pick · Low Float Bullish Consensus Deep RotationGPIBUY NOW8.2 / 108/12/2026

Group 1 Automotive (GPI) is the cleanest risk/reward on the board: a $3.17B consumer cyclical trading at a P/E of 11.1, forward P/E of 6.05, PEG 0.86, with a positive ROE of 9.4% and profit margin of 1.29% — genuinely investable fundamentals in a lens dominated by cash-burning micro-caps. Analyst recom is 2.0 with a 39.7% target upside, and institutional ownership at 100.23% hints at meaningful short pressure (shortFloat 8.38%) that could accelerate any bounce. The tape confirms across every timeframe with rare unanimity. 4h forecast is +29.3/+35.3/+40.5% short/mid/long; 1d is +19.5/+44.1/+40.4%; even the 1wk pivots positive at +11.3/+15.1% mid/long. Near_term_bullish is 1.0 and bullish_prob is 1.0. Critically, position_in_21bar_range_pct is 4.86% (4h), 1.23% (1d) and 0.0% (1wk) — the stock is pinned at the bottom of its range with drawdowns of −10.97%/−25.62%/−25.46% and RSI at 35.13 (oversold). This is the definition of not chasing. Why today and not later: RSI 35 + zero position in weekly range + bullish multi-TF forecasts is the exact setup where mean reversion tends to fire quickly. The Morgan Stanley downgrade on 8/8 is a real headwind and I flag it — but the Simply Wall St. valuation note the same day and the branding overhaul suggest the reaction is already priced into a stock down 32% YTD and 38% YoY. Waiting risks missing the reversion. Compared to BESS (fc strong but 1d position 76% — chasing), MORN (top of range 82-88%, weak fc +1-4%), USNA (strong tape but recom 3 and negative margins), and ANNA (great growth but zero analyst coverage), GPI offers the best marriage of real fundamentals, deep-value entry, and confirmed forecast tape.

GPI forecast chart
Entry zone
$263-$268 (current $266.26, scale in on any dip toward $260)
Stop loss
$248 (below 21-bar weekly low, ~7% risk, invalidates oversold bounce thesis)
First target
$298-$305 (aligns with 4h fc_short +29% and reclaims mid-range on daily)
Longer target
$355-$372 (matches analyst 39.7% upside and 4h/1d mid forecast +40-44%)
Risks
  • Morgan Stanley downgrade on 8/8/2026 could pressure the tape short-term and cap initial rally
  • Auto retail cyclical exposure — debtEq at 1.96 is elevated for a slowing consumer environment
  • 1wk fc_short is slightly negative (−2.91%) suggesting near-term chop before the mid-term bounce
  • shortFloat 8.38% cuts both ways — squeeze potential but also indicates informed skeptics
  • Sales YoY only +0.81% and profit margin 1.29% mean any consumer weakness compresses earnings fast
Honorable mentions
ANNAAll three TFs bullish (4h/1d/1wk fc +56-64%/+26-46%/+240-284%), position at bottom of range (0-3.5%), sales YoY +1533%, roe 17.97%, profit margin 17.43%, positive 'Italy's Gas Revival' catalyst. Loses to GPI only because targetUpsidePct is null (no analyst coverage) and 1wk +284% fc looks like an outlier magnitude.
BESSTop screen score 13.5, fwdPe 4.68, targetUpsidePct 173.9%, strong 4h fc (+54/+82/+67%), and legitimate positive catalysts ($6.4M cash received, Wildfire BESS project selection, WSJ profile). Docked for being at 76% of daily range — better to wait for pullback than chase into a micro-cap ($25M) at intra-range highs.
Full ranking (30)
#SymbolVerdictScoreRead
1GPIBUY NOW8.2Cheap large-cap (P/E 11, PEG 0.86) pinned at 0-5% of range with unanimous multi-TF bullish forecasts and RSI 35.
2ANNABUY NOW7.8Profitable energy micro-cap (roe 17.97, margin 17.43) at bottom of range with all-TF bullish forecasts and Italy gas catalyst.
3BESSBUY PULLBACK7.4Screen leader with fwdPe 4.68 and fresh positive news but 1d position 76% argues for entry on dip to $3.20.
4IDNBUY NOW7.0Profitable tech (margin 9.56, gross 90.68) at 3-44% of range with 4h/1d fc +36-59% and Q1 profit flip catalyst.
5USNABUY PULLBACK6.7RSI 25.88, position 0% weekly, all four TFs bullish with 1wk fc +166% long — but recom 3.0 and profit margin −2.43% keep this a pullback play.
6BCDABUY PULLBACK6.41wk fc +108-162% and prior FDA path support, but sales YoY −100% and ROE −950 demand tiny size.
7EVGNBUY PULLBACK6.2All-TF bullish (fc +25-118%), positive PCSK9 and antifungal news, but sales YoY −72.74% is a warning.
8MORNWAIT5.9Best pure fundamentals (ROE 32, PEG 0.75) but at 82-88% of range with 4h fc −5.4% — no entry today.
9QNTMBUY PULLBACK5.7Fresh FDA clearance for MS trial is a real catalyst but position at 97% of daily range = chasing.
10GLMDBUY PULLBACK5.4Only two TFs available but both bullish (fc +33-86%), Parkinson's/cardiac pipeline news positive.
11CNCKWAIT5.2Q1 beat but 56M share resale prospectus (7/31) is overhang; 4h fc only +12.6% short.
12LTRNWAIT5.0EMA Phase 1b/2 clearance is positive but 4h fc is −5 to −10% and epsNextY −33.77.
13NXTCWAIT4.9Q2 EPS miss (−2.80 vs −1.94) and merger-CVR structure complicates thesis despite 1wk fc +71%.
14XTLBWAIT4.71wk fc +115-158% intriguing but $6M cap and no fundamentals visibility.
15TNXPWAIT4.5TONMYA launch narrative real but 1wk fc +51,965% is an unusable outlier — need clean signal.
16PRSOWAIT4.4Multi-TF fc positive but sales YoY −40.57% and profit margin −73 don't support conviction.
17LBRDAWAIT4.3At 100% of 4h/1d range, new dividend but salesYoY −100% and epsNextY −23.18 — chasing.
18RGNTWAIT4.1Positive Japan/EU regulatory news but only 1d TF available and RSI 40.3.
19AKTXAVOID3.91wk fc −76.99% completely undercuts the shorter-TF bullish signals — broken tape.
20INDPWAIT3.81wk fc +850% is a bottom-fishing lottery ticket after −60% 21-bar drop; ROE −932 is dire.
21NXLWAIT3.7Positive Brazil trial news but operMargin −3084 and 1wk fc mid is −33.79%.
22IPWRWAIT3.6NVIDIA ecosystem LOI is a real catalyst but 4h fc mid/long turn negative (−0.5/−5.14%).
23LUCYWAIT3.51d fc +120% attractive but $6M cap, recom 3.0, margin −272 and only 2 TFs available.
24CDNLWAIT3.4Only 1d TF available; earnings just reported, RSI 24.75 oversold — needs more signal.
25YCBDWAIT3.21d fc_short −8.37% and only 2 TFs available; margin −15.56 keeps this speculative.
26GRCEAVOID3.0$10M private placement on 8/5 is dilution; 1wk fc essentially flat despite FDA meeting minutes.
27INTZAVOID2.9Q2 EPS and revenue miss on 8/11 plus 1wk fc −51.74% = broken setup.
28TASKWAIT2.8Morgan Stanley Equal-Weight $7 PT and 'client automation' overhang; near_term_bullish 0.
29USBCAVOID2.51d fc_short −48.15%, near_term_bullish 0, at 100% of daily range — every red flag lit.
30COSMAVOID1.81wk fc −100% overrides everything; roe −92, margin −30 — capital destruction risk.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.